Pérez-Rodríguez, S., de la Caridad Rodríguez-González, M., Ochoa-Azze, R., Climent-Ruiz, Y., Alberto González-Delgado, C., Paredes-Moreno, B., . . . Verez-Bencomo, V. (2022). A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity. Vaccine, 40(13), 2068-2075. https://doi.org/10.1016/j.vaccine.2022.02.029
Citace podle Chicago (17th ed.)Pérez-Rodríguez, Sonia, et al. "A Randomized, Double-blind Phase I Clinical Trial of Two Recombinant Dimeric RBD COVID-19 Vaccine Candidates: Safety, Reactogenicity and Immunogenicity." Vaccine 40, no. 13 (2022): 2068-2075. https://doi.org/10.1016/j.vaccine.2022.02.029.
Citace podle MLA (9th ed.)Pérez-Rodríguez, Sonia, et al. "A Randomized, Double-blind Phase I Clinical Trial of Two Recombinant Dimeric RBD COVID-19 Vaccine Candidates: Safety, Reactogenicity and Immunogenicity." Vaccine, vol. 40, no. 13, 2022, pp. 2068-2075, https://doi.org/10.1016/j.vaccine.2022.02.029.